Related Experiment Videos
Argon laser trabeculoplasty: long-term results
R Lotti1, C E Traverso, U Murialdo
1University Eye Clinic, Genova, Italy.
Ophthalmic Surgery
|March 1, 1995
Summary
Argon laser trabeculoplasty (ALT) shows high initial success in treating primary open-angle glaucoma. However, its effectiveness decreases over time, with long-term success rates declining significantly after 10 years.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Interventions
Background:
- Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness.
- Argon laser trabeculoplasty (ALT) is a common surgical option for managing POAG.
- Long-term efficacy data for ALT is crucial for clinical decision-making.
Purpose of the Study:
- To evaluate the long-term success of argon laser trabeculoplasty (ALT) in patients with primary open-angle glaucoma (POAG).
- To determine the cumulative success rates of ALT over an 11-year follow-up period.
Main Methods:
- A retrospective analysis of 237 eyes from 175 patients with POAG treated with ALT.
- Kaplan-Meier life-table analysis was used to calculate cumulative success rates.
- Success was defined as avoiding glaucoma surgery or maintaining intraocular pressure (IOP) below 22 mm Hg.
Main Results:
- Initial success rates were high, with 78% at 1 year.
- Success rates demonstrated a time-dependent decline: 71% at 3 years, 61% at 5 years, and 40% at 10.5 years.
- The study confirms previous findings on the initial efficacy and subsequent decline of ALT.
Conclusions:
- Argon laser trabeculoplasty (ALT) provides significant initial IOP reduction and glaucoma control.
- The efficacy of ALT diminishes over time, necessitating careful long-term monitoring and potential retreatment or alternative surgical interventions.
- ALT remains a valuable option for initial glaucoma management, but its long-term durability requires consideration.